Search - tctmd.com

Displaying 821 - 840 of 1167

Sort: Relevancy | Date

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Industry News

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Industry News

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

September 13, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Industry News

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

September 13, 2014

News Industry News

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

September 12, 2014

News Daily News

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

September 11, 2014

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

Advertisement

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

TCT Course Director Outlines Current TAVR Controversies

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Lively Debate on Use of TAVR for Lower-Risk Patients

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content